IHE ETF

IHE ETF
$111.08
See how much of IHE you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
+6.15%
3 Months
+4.90%
6 Months
+21.62%
YTD
+25.63%
1 Year
+40.30%
3 Years (annualized)
+24.07%
5 Years (annualized)
+11.18%
10 Years (annualized)
+8.88%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IHE have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Dow Jones US Select Pharmaceuticals Index(^DJSPHM)
This ETF (YTD)
+25.63%
Peer Avg (YTD)
+12.41%
vs Peers
+13.22%

IHE ETF Performance

IHE performance across multiple time periods: 1-month 6.15%, YTD 25.63%, 1-year 40.30%, 3-year 24.07%, 5-year 11.18%, 10-year 8.88%.

IHE returns outperform the peer average of 12.41% YTD. With an expense ratio of 0.37%, investors should weigh costs against performance when evaluating this ETF.

IHE vs another fund shows side-by-side returns. IHE alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal Return
1 Month+6.15%
3 Months+4.90%
6 Months+21.62%
1 Year+40.30%
3 Years+24.07%
5 Years+11.18%

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized. Return figures last updated Nov 8, 2026.